NM_022168.4:c.2105C>T

Variant summary

Our verdict is Benign. Variant got -18 ACMG points: 2P and 20B. PM1BP4_StrongBP6_Very_StrongBS1BS2

The NM_022168.4(IFIH1):​c.2105C>T​(p.Thr702Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00331 in 1,612,420 control chromosomes in the GnomAD database, including 20 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0025 ( 2 hom., cov: 32)
Exomes 𝑓: 0.0034 ( 18 hom. )

Consequence

IFIH1
NM_022168.4 missense

Scores

19

Clinical Significance

Likely benign criteria provided, multiple submitters, no conflicts B:7

Conservation

PhyloP100: -0.177
Variant links:
Genes affected
IFIH1 (HGNC:18873): (interferon induced with helicase C domain 1) IFIH1 encodes MDA5 which is an intracellular sensor of viral RNA that triggers the innate immune response. Sensing RNA length and secondary structure, MDA5 binds dsRNA oligonucleotides with a modified DExD/H-box helicase core and a C-terminal domain, thus leading to a proinflammatory response that includes interferons. It has been shown that Coronaviruses (CoVs) as well as various other virus families, are capable of evading the MDA5-dependent interferon response, thus impeding the activation of the innate immune response to infection. MDA5 has also been shown to play an important role in enhancing natural killer cell function in malaria infection. In addition to its protective role in antiviral responses, MDA5 has been implicated in autoimmune and autoinflammatory diseases such as type 1 diabetes, systemic lupus erythematosus, and Aicardi-Goutieres syndrome[provided by RefSeq, Jul 2020]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -18 ACMG points.

PM1
In a domain Helicase C-terminal (size 182) in uniprot entity IFIH1_HUMAN there are 6 pathogenic changes around while only 2 benign (75%) in NM_022168.4
BP4
Computational evidence support a benign effect (MetaRNN=0.0051235557).
BP6
Variant 2-162276886-G-A is Benign according to our data. Variant chr2-162276886-G-A is described in ClinVar as [Likely_benign]. Clinvar id is 541787.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-162276886-G-A is described in Lovd as [Likely_benign].
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.00248 (377/152120) while in subpopulation NFE AF= 0.00431 (293/67988). AF 95% confidence interval is 0.0039. There are 2 homozygotes in gnomad4. There are 162 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 2 AD,AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
IFIH1NM_022168.4 linkc.2105C>T p.Thr702Ile missense_variant Exon 11 of 16 ENST00000649979.2 NP_071451.2 Q9BYX4-1
IFIH1XM_047445407.1 linkc.1388C>T p.Thr463Ile missense_variant Exon 10 of 15 XP_047301363.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
IFIH1ENST00000649979.2 linkc.2105C>T p.Thr702Ile missense_variant Exon 11 of 16 NM_022168.4 ENSP00000497271.1 Q9BYX4-1

Frequencies

GnomAD3 genomes
AF:
0.00248
AC:
377
AN:
152002
Hom.:
2
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000628
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00157
Gnomad ASJ
AF:
0.00404
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00103
Gnomad FIN
AF:
0.000661
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.00431
Gnomad OTH
AF:
0.00336
GnomAD3 exomes
AF:
0.00235
AC:
587
AN:
249830
Hom.:
0
AF XY:
0.00248
AC XY:
334
AN XY:
134912
show subpopulations
Gnomad AFR exome
AF:
0.000432
Gnomad AMR exome
AF:
0.00111
Gnomad ASJ exome
AF:
0.00408
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.000766
Gnomad FIN exome
AF:
0.000601
Gnomad NFE exome
AF:
0.00397
Gnomad OTH exome
AF:
0.00246
GnomAD4 exome
AF:
0.00340
AC:
4964
AN:
1460300
Hom.:
18
Cov.:
31
AF XY:
0.00343
AC XY:
2492
AN XY:
726402
show subpopulations
Gnomad4 AFR exome
AF:
0.000599
Gnomad4 AMR exome
AF:
0.00128
Gnomad4 ASJ exome
AF:
0.00398
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.000524
Gnomad4 FIN exome
AF:
0.000955
Gnomad4 NFE exome
AF:
0.00399
Gnomad4 OTH exome
AF:
0.00384
GnomAD4 genome
AF:
0.00248
AC:
377
AN:
152120
Hom.:
2
Cov.:
32
AF XY:
0.00218
AC XY:
162
AN XY:
74376
show subpopulations
Gnomad4 AFR
AF:
0.000626
Gnomad4 AMR
AF:
0.00157
Gnomad4 ASJ
AF:
0.00404
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00104
Gnomad4 FIN
AF:
0.000661
Gnomad4 NFE
AF:
0.00431
Gnomad4 OTH
AF:
0.00332
Alfa
AF:
0.00360
Hom.:
1
Bravo
AF:
0.00243
TwinsUK
AF:
0.00431
AC:
16
ALSPAC
AF:
0.00337
AC:
13
ESP6500AA
AF:
0.000454
AC:
2
ESP6500EA
AF:
0.00314
AC:
27
ExAC
AF:
0.00219
AC:
266
Asia WGS
AF:
0.000577
AC:
2
AN:
3478
EpiCase
AF:
0.00536
EpiControl
AF:
0.00523

ClinVar

Significance: Likely benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:4
-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance: Likely benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

-
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance: Likely benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

Mar 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

IFIH1: BP4, BS2 -

-
Breakthrough Genomics, Breakthrough Genomics
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: not provided

- -

Aicardi-Goutieres syndrome 7 Benign:1
Jun 30, 2020
Genetics and Molecular Pathology, SA Pathology
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Aicardi-Goutieres syndrome 7;C4225427:Singleton-Merten syndrome 1 Benign:1
Feb 02, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

IFIH1-related disorder Benign:1
Feb 25, 2020
PreventionGenetics, part of Exact Sciences
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.084
BayesDel_addAF
Benign
-0.72
T
BayesDel_noAF
Benign
-0.80
CADD
Benign
1.3
DANN
Benign
0.89
DEOGEN2
Benign
0.11
T;T;.
Eigen
Benign
-1.3
Eigen_PC
Benign
-1.3
FATHMM_MKL
Benign
0.073
N
LIST_S2
Benign
0.64
.;T;T
M_CAP
Benign
0.0031
T
MetaRNN
Benign
0.0051
T;T;T
MetaSVM
Benign
-0.98
T
MutationAssessor
Benign
1.0
L;L;.
PrimateAI
Benign
0.31
T
PROVEAN
Benign
-1.6
.;N;.
REVEL
Benign
0.030
Sift
Benign
0.23
.;T;.
Sift4G
Benign
0.22
.;T;.
Polyphen
0.0
B;B;.
Vest4
0.15
MVP
0.15
MPC
0.025
ClinPred
0.0012
T
GERP RS
-5.6
Varity_R
0.076
gMVP
0.14

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs72650663; hg19: chr2-163133396; API